CN103734716A - Branched chain amino acid - Google Patents
Branched chain amino acid Download PDFInfo
- Publication number
- CN103734716A CN103734716A CN201310693215.1A CN201310693215A CN103734716A CN 103734716 A CN103734716 A CN 103734716A CN 201310693215 A CN201310693215 A CN 201310693215A CN 103734716 A CN103734716 A CN 103734716A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- chain amino
- branched chain
- valine
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000005693 branched-chain amino acids Chemical class 0.000 title claims abstract description 22
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 11
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004474 valine Substances 0.000 claims abstract description 10
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 8
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 claims abstract description 6
- 229960000310 isoleucine Drugs 0.000 claims abstract description 6
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 abstract description 18
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 abstract description 18
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 10
- 239000010931 gold Substances 0.000 abstract description 10
- 229910052737 gold Inorganic materials 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241001379910 Ephemera danica Species 0.000 description 2
- 102000008934 Muscle Proteins Human genes 0.000 description 2
- 108010074084 Muscle Proteins Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- XDDMZVMWZMSAMX-JHNJPSDUSA-N (2s,3s)-2-azanyl-3-methyl-pentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O XDDMZVMWZMSAMX-JHNJPSDUSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 101000807541 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 24 Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 102000007001 Period Circadian Proteins Human genes 0.000 description 1
- 108010047728 Period Circadian Proteins Proteins 0.000 description 1
- 102100037176 Ubiquitin carboxyl-terminal hydrolase 24 Human genes 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a branched chain amino acid. The branched chain amino acid is prepared from the components: leucine, isoleucine and valine, wherein the mass ratio of the leucine, the isoleucine to the valine is 48.5 percent: 24.92 percent: 26.6 percent. With the adoption of the branched chain amino acid, as the actual additive amount is regulated according to the actual conditions of China raw material market, ideal gold proportion is achieved, and the branched chain amino acid BCAA which has the effects of strengthening body health and prolonging the life achieves the optimal health-care effect.
Description
Technical field
The present invention relates to a kind of branched-chain amino acid.
Background technology
Scientist has found a kind of medicine that can promote longevity, and small white mouse, has tested with it, succeeds first.The medicine of this mystery is exactly the mixture being comprised of this 3 seed amino acid of leucine, isoleucine and valine, formal name used at school " branched-chain amino acid ".
Branched-chain amino acid (BCAA:Branched Chain Amino Acids) refers to a group amino acid that contains side chain in structure, has comprised leucine, isoleucine, valine.This three seed amino acid belongs to essential amino acid, has inseparable relation with synthetic protein, need not pass through body metabolism, just can directly provide energy to use to human body.In human body, approximately 33% muscle protein is to be become by BCAA Group, accounts for essential amino acid approximately 35% left and right.
The motion (for example: heavily instruction, extreme sport, body-building) of middle intensity can cause the content fast-descending of BCAA to cause the concentration of catabolism, fatigue and the Testosterone (stosterone) of muscle to decline.BCAA is the pith of muscle protein, and when the BCAA in blood of human body is inadequate, the BCCA that just can decompose in muscle makes the energy, produce power, carbon dioxide and water.During training, in skeletal muscle, the consumption of BCAA is very fast, supplements branched-chain amino acid and can improve locomitivity, delay fatigue, the reparation muscle because of motion loss before motion or in motion.After motion, with canteen, with BCAA, contribute to other amino acid whose absorption at once or after motion.
The main function of BCAA has: recover health moisture and electrolyte, recover glycogen deposit rapidly, strengthen muscular endurance, rebuild intramuscular protein.Generally speaking, the function of BCAA is the synthetic and metabolism for promoting rest period protein, except accelerating the synthetic decomposition that can also reduce musculature of muscle, and BCAA has good anti-decomposability, can be used for preventing the loss of muscle and protein, can also stimulate insulin, promote muscle to other amino acid whose absorptions simultaneously.
In brief, the function of BCAA is as follows:
1. promote muscular endurance growth;
2. recover the muscular strength running off after motion;
3. safeguard muscle cell and protection musculature;
4. prevent that muscle runs off;
5. life-extending.
Owing to existing the relation of competition each other between BCAA when absorbing, therefore must supplement with Time, just can guarantee best assimilation effect.
In nutrition science, three kinds of main components of BCAA: leucine, isoleucine, valine, owing to existing the relation of competition each other when absorbing, just can be guaranteed best effect so must supplement simultaneously.According to conventional formulation, BCAA is take 2:1:1 as optimum formula always, is known as " gold proportioning ".As long as generally acknowledge and reach " gold proportioning ", just can play the most perfectly nutritive validity.
The current main manufacturer of domestic branched-chain amino acid is Yichang Sanxia Pharmaceutical Co., Ltd., Shandong Fu Feng fermentation group, the biological group of Shandong Lu Zhou etc., due to technological reason, these producers are mainly used Studies on Fermentation of L-isoleucine, Valine, all with fermentation method, do not produce leucine, so mainly still extract from human hair, drake feather, pig hair in domestic leucine source.Immature due to extraction process, domestic all production ILEs and Valine factory can only produce the product of USP24 rank, its purity detects and can only reach 93%-95% with HPLC, and the use of leucine manufacturer is Hydrolyze method, extraction process is used the precipitation method, comparative maturity on separation-extraction technology, its leucine detects effective purity more than 99% with HPLC, so three seed amino acids in theory the gold proportioning of 2:1:1 be really to reach perfect combination.
Because current branched-amino acid starting material mainly comes from China, because the production status of current Chinese branched-chain amino acid, American-European countries all reaches " gold proportioning " on theory significance by adjusting these three amino acid whose proportionings.
Summary of the invention
The technical problem to be solved in the present invention is the defect that overcomes prior art, and a kind of branched-chain amino acid is provided, and this branched-chain amino acid is real has reached " gold proportioning ".
In order to solve the problems of the technologies described above, the invention provides following technical scheme:
A kind of branched-chain amino acid of the present invention, comprises leucine, isoleucine and valine, and the mass ratio of described leucine, isoleucine and valine is leucine: isoleucine: valine=48.45%:24.92%:26.63%.
Branched-chain amino acid provided by the invention, according to the actual conditions of Chinese raw materials market, has adjusted actual addition, has reached desirable " gold proportioning ", allows the branched-chain amino acid BCAA that improves the health, promotes longevity reach top health-care effect.
The specific embodiment
Below the preferred embodiments of the present invention are described, should be appreciated that preferred embodiment described herein, only for description and interpretation the present invention, is not intended to limit the present invention.
Current domestic branched-chain amino acid producer is mainly the producer of Studies on Fermentation of L-isoleucine (L-ISOLEUCINE) and Valine (L-VALINE) and the producer that Hydrolyze method is extracted L-Leu (L-LEUCINE) from human hair, drake feather, pig hair.Due in fermentation production process, while being accompanied by the growth of ILE and Valine strain fermentation, other amino acid also, simultaneously in growth, adds the immature of purifying technique, and it is desirable more than 99% that the HPLC purity of ILE and Valine reaches far away.High efficiency liquid phase (HPLC) the detection level data of these three product domestic raw material are as follows at present:
So according to the proportioning of theoretic 2:1:1, actual mixed L-Leu, ILE, the content of Valine is:
Visible, so-called BCAA scientific matching cannot really reach the ideal effect of " gold proportioning " in fact in the market;
The present invention, according to the actual conditions of Chinese raw materials market, has adjusted actual addition, has reached desirable " gold proportioning ", allows the branched-chain amino acid BCAA that improves the health, promotes longevity reach top health-care effect:
Visible, branched-chain amino acid provided by the invention, real having reached " gold proportioning ", can better reach the effect of nutrition.
Finally it should be noted that: the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although the present invention is had been described in detail with reference to previous embodiment, for a person skilled in the art, its technical scheme that still can record aforementioned each embodiment is modified, or part technical characterictic is wherein equal to replacement.Within the spirit and principles in the present invention all, any modification of doing, be equal to replacement, improvement etc., within all should being included in protection scope of the present invention.
Claims (1)
1. a branched-chain amino acid, comprises leucine, isoleucine and valine, it is characterized in that, the mass ratio of described leucine, isoleucine and valine is leucine: isoleucine: valine=48.45%:24.92%:26.63%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310693215.1A CN103734716A (en) | 2013-12-16 | 2013-12-16 | Branched chain amino acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310693215.1A CN103734716A (en) | 2013-12-16 | 2013-12-16 | Branched chain amino acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103734716A true CN103734716A (en) | 2014-04-23 |
Family
ID=50491853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310693215.1A Pending CN103734716A (en) | 2013-12-16 | 2013-12-16 | Branched chain amino acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103734716A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104757563A (en) * | 2015-04-24 | 2015-07-08 | 刘尚文 | Weight-losing health food and preparation method thereof |
| CN105214094A (en) * | 2015-10-27 | 2016-01-06 | 无锡金维氨生物科技有限公司 | The branched-chain amino acid powder that a kind of bulk density improves |
| CN105249127A (en) * | 2015-10-27 | 2016-01-20 | 无锡金维氨生物科技有限公司 | Flavor type instant branched chain amino acid solid beverage |
| CN105288638A (en) * | 2015-10-27 | 2016-02-03 | 无锡金维氨生物科技有限公司 | Method for improving bulk density of branched chain amino acid powder |
| CN105614441A (en) * | 2014-12-01 | 2016-06-01 | 无锡金维氨生物科技有限公司 | Instant branched-chain amino acid SBCAA |
| CN107708659A (en) * | 2015-12-14 | 2018-02-16 | 有限会社Ant | It is compounded with the face skin preparations for extenal use of amino acid |
| CN107997183A (en) * | 2017-12-25 | 2018-05-08 | 大连医诺生物股份有限公司 | Microencapsulation is sustained branched-chain amino acid |
| CN108283314A (en) * | 2017-11-30 | 2018-07-17 | 新疆阜丰生物科技有限公司 | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1625346A (en) * | 2002-02-22 | 2005-06-08 | 味之素株式会社 | Powder of amino acids and method for producing the same |
| CN102149374A (en) * | 2008-09-09 | 2011-08-10 | 味之素株式会社 | Orally administrable formulation containing branched chain amino acid |
| CN102458417A (en) * | 2009-06-24 | 2012-05-16 | 味之素株式会社 | Enhancer of activity of nucleic acid analogue |
| CN103070330A (en) * | 2011-10-25 | 2013-05-01 | 北京康比特体育科技股份有限公司 | Anti-fatigue nutritional bar and preparation method thereof |
-
2013
- 2013-12-16 CN CN201310693215.1A patent/CN103734716A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1625346A (en) * | 2002-02-22 | 2005-06-08 | 味之素株式会社 | Powder of amino acids and method for producing the same |
| CN102149374A (en) * | 2008-09-09 | 2011-08-10 | 味之素株式会社 | Orally administrable formulation containing branched chain amino acid |
| CN102458417A (en) * | 2009-06-24 | 2012-05-16 | 味之素株式会社 | Enhancer of activity of nucleic acid analogue |
| CN103070330A (en) * | 2011-10-25 | 2013-05-01 | 北京康比特体育科技股份有限公司 | Anti-fatigue nutritional bar and preparation method thereof |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105614441A (en) * | 2014-12-01 | 2016-06-01 | 无锡金维氨生物科技有限公司 | Instant branched-chain amino acid SBCAA |
| CN104757563A (en) * | 2015-04-24 | 2015-07-08 | 刘尚文 | Weight-losing health food and preparation method thereof |
| CN105214094A (en) * | 2015-10-27 | 2016-01-06 | 无锡金维氨生物科技有限公司 | The branched-chain amino acid powder that a kind of bulk density improves |
| CN105249127A (en) * | 2015-10-27 | 2016-01-20 | 无锡金维氨生物科技有限公司 | Flavor type instant branched chain amino acid solid beverage |
| CN105288638A (en) * | 2015-10-27 | 2016-02-03 | 无锡金维氨生物科技有限公司 | Method for improving bulk density of branched chain amino acid powder |
| CN105249127B (en) * | 2015-10-27 | 2017-11-17 | 江苏金维氨生物工程有限公司 | A kind of instant branched-chain amino acid solid beverage of flavor type |
| CN105214094B (en) * | 2015-10-27 | 2017-11-21 | 江苏金维氨生物工程有限公司 | The branched-chain amino acid pulvis that a kind of bulk density improves |
| CN107708659A (en) * | 2015-12-14 | 2018-02-16 | 有限会社Ant | It is compounded with the face skin preparations for extenal use of amino acid |
| CN107708659B (en) * | 2015-12-14 | 2020-07-03 | 有限会社Ant | External preparation for facial skin containing amino acids |
| CN108283314A (en) * | 2017-11-30 | 2018-07-17 | 新疆阜丰生物科技有限公司 | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof |
| CN107997183A (en) * | 2017-12-25 | 2018-05-08 | 大连医诺生物股份有限公司 | Microencapsulation is sustained branched-chain amino acid |
| CN107997183B (en) * | 2017-12-25 | 2021-10-22 | 大连医诺生物股份有限公司 | Microencapsulated sustained-release branched-chain amino acids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103734716A (en) | Branched chain amino acid | |
| CN104000017A (en) | Grass-free feed for sheep | |
| EP2726625A1 (en) | Method for production of natural l-cysteine by fermentation | |
| CN102429236B (en) | Method for preparing pig bone collagen polypeptide chelated calcium supplement | |
| CN103724218A (en) | New crystallization technology of lysine hydrochloride | |
| CN106173475A (en) | Alleviate mixed feed of broiler heat stress and preparation method thereof | |
| CN105777312A (en) | Millet composite foliar fertilizer | |
| CN102924181A (en) | Vegetable amino acid liquid fertilizer and preparing method | |
| CN105360846A (en) | Amino acid beverage | |
| CN101926412B (en) | Production method of compound amino acid feed additive rich in gamma-aminobutyric acid (GABA) | |
| CN105087702A (en) | Method for preparing sodium glutamate through concentrating continuous freezing isoelectric point crystallization | |
| CN110241147B (en) | Method for co-producing succinic acid by fermenting L-malic acid | |
| CN106472670B (en) | Sports nutritional fermented milk and preparation method thereof | |
| CN105063159A (en) | Novel process for extracting glutamic acid through concentration-continuous isoelectric treatment | |
| CN107095309A (en) | Marine organisms composite calcium powder, preparation method thereof | |
| CN106086093A (en) | The method that lactate fermentation thalline slag preprocess method and circulating fermentation produce lactic acid | |
| CN103224454A (en) | Glutamic acid separating and extracting technology | |
| CN103250903B (en) | Efficacy nutritive cream for fur-bearing animal and preparation method thereof | |
| CN103284260A (en) | California walnut dew containing endopleura and preparation method thereof | |
| CN108354183A (en) | The method for preparing the compound calcium powder of high-quality ocean source amino acid | |
| RU2441370C2 (en) | Method of enrichment of stimulating extra nutrition for bees | |
| CN101690539B (en) | Method for producing feed by utilizing collagen polypeptide liquid | |
| CN1559271A (en) | Method for preparing gamma-amino butyric acid rich type rice germ flour, and its application | |
| CN105039487A (en) | Novel concentrating and continuous isoelectric extraction technology for glutamic acid | |
| CN107372328B (en) | Production method of sports function food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140423 |